July 1, 2026 · Form 4 insider transaction
Bhalla Narinder Pal sold 22,306 shares of Lexeo Therapeutics, Inc. at $4.42 per share, a transaction worth $98.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Represents a sale to cover tax obligations on the release of performance Restricted Stock Units ("RSUs").; This transaction was executed in multiple trades at prices ranging from $4.341 to $4.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.; Includes 49,500 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.